Resources

Results per page

Selected Filters:

Drug discovery > Clinical Development Clear Filters

Application Notes

Overcoming Obstacles to Develop a Cancer Immunotherapeutic

18 Aug 2014

White Papers

Managing Risk and Driving Profitability with Today's Process Analytical Technologies in the Pharmaceutical Industry

17 Aug 2014

Application Notes

Eppendorf Cell Culture Consumables –Improved Optical Performance Facilitates Microscopic Analysis of Cells

6 Aug 2014

White Papers

7 Ways to Reduce Inflammation Study Challenges

4 Jun 2014

White Papers

Advanced Batch Control

1 Jun 2014

Case Studies

The Nut Thing - Oral Immunotherapy, a Personal Journey

1 Jun 2014

White Papers

Practical Solutions for Poorly Soluble Drugs

29 May 2014

White Papers

Improved Production Yield through Computer Based Formulation / Recipe Weighing

28 May 2014

White Papers

Traceability for Consumer Safety and Process Improvement’

28 May 2014

White Papers

Hygienic Designed Scales - Less Contamination and Enhanced Profits

26 May 2014

Scientific Posters

CAR mRNA Loaded Freshly Isolated Peripheral Blood Lymphocytes as Rapid, Targeted Tumor Immunotherapy

18 May 2014

White Papers

Unraveling the Exclusivity Determination for Prodrugs

11 May 2014

White Papers

Why More Drugs than Ever are Approved Through 505(b)(2)

11 May 2014

Application Notes

MALDI Imaging Success Stories in Clinical Research

7 May 2014

Application Notes

Blister Pack Blues: The Struggle to Extract Vital Medication

24 Apr 2014

Application Notes

Quality Packaging: Pharmaceutical Industry

22 Apr 2014

White Papers

Identifying Products for Drug Development Programs

15 Mar 2014

Application Notes

Particle Size Determination in Pharmaceutical Applications

11 Mar 2014

Scientific Posters

eCiphrNeuro: A High Throughput Assay to Detect Neurotoxic Compounds in Early Drug Discovery

10 Mar 2014

Application Notes

Determination of the Particle Size Distribution for Procaine

10 Mar 2014

White Papers

Understanding the 505(b)(2) Approval Pathway

10 Mar 2014

Scientific Posters

CMC for 505(b)(2) Applications

10 Mar 2014

Application Notes

Measurement of Elemental Impurities in Pharmaceutical Products by ICP-AES and ETAAS

25 Feb 2014

Application Notes

ImmunoSIGNAL™ Cytokine Storm

10 Dec 2013

Application Notes

Development of an In Vitro Pre-clinical Cellular Assay to Predict

9 Dec 2013

Resources

Resources Filter

Search

Selected Filters:

Overcoming Obstacles to Develop a Cancer Immunotherapeutic

Managing Risk and Driving Profitability with Today's Process Analytical Technologies in the Pharmaceutical Industry

Eppendorf Cell Culture Consumables –Improved Optical Performance Facilitates Microscopic Analysis of Cells

7 Ways to Reduce Inflammation Study Challenges

Advanced Batch Control

The Nut Thing - Oral Immunotherapy, a Personal Journey

Practical Solutions for Poorly Soluble Drugs

Improved Production Yield through Computer Based Formulation / Recipe Weighing

Traceability for Consumer Safety and Process Improvement’

Hygienic Designed Scales - Less Contamination and Enhanced Profits

CAR mRNA Loaded Freshly Isolated Peripheral Blood Lymphocytes as Rapid, Targeted Tumor Immunotherapy

Unraveling the Exclusivity Determination for Prodrugs

Why More Drugs than Ever are Approved Through 505(b)(2)

MALDI Imaging Success Stories in Clinical Research

Blister Pack Blues: The Struggle to Extract Vital Medication

Quality Packaging: Pharmaceutical Industry

Identifying Products for Drug Development Programs

Particle Size Determination in Pharmaceutical Applications

eCiphrNeuro: A High Throughput Assay to Detect Neurotoxic Compounds in Early Drug Discovery

Determination of the Particle Size Distribution for Procaine

Understanding the 505(b)(2) Approval Pathway

CMC for 505(b)(2) Applications

Measurement of Elemental Impurities in Pharmaceutical Products by ICP-AES and ETAAS

ImmunoSIGNAL™ Cytokine Storm

Development of an In Vitro Pre-clinical Cellular Assay to Predict

Resources

Resources FilterResources Filter

Search

Selected Filters:

Overcoming Obstacles to Develop a Cancer Immunotherapeutic

Managing Risk and Driving Profitability with Today's Process Analytical Technologies in the Pharmaceutical Industry

Eppendorf Cell Culture Consumables –Improved Optical Performance Facilitates Microscopic Analysis of Cells

7 Ways to Reduce Inflammation Study Challenges

Advanced Batch Control

The Nut Thing - Oral Immunotherapy, a Personal Journey

Practical Solutions for Poorly Soluble Drugs

Improved Production Yield through Computer Based Formulation / Recipe Weighing

Traceability for Consumer Safety and Process Improvement’

Hygienic Designed Scales - Less Contamination and Enhanced Profits

CAR mRNA Loaded Freshly Isolated Peripheral Blood Lymphocytes as Rapid, Targeted Tumor Immunotherapy

Unraveling the Exclusivity Determination for Prodrugs

Why More Drugs than Ever are Approved Through 505(b)(2)

MALDI Imaging Success Stories in Clinical Research

Blister Pack Blues: The Struggle to Extract Vital Medication

Quality Packaging: Pharmaceutical Industry

Identifying Products for Drug Development Programs

Particle Size Determination in Pharmaceutical Applications

eCiphrNeuro: A High Throughput Assay to Detect Neurotoxic Compounds in Early Drug Discovery

Determination of the Particle Size Distribution for Procaine

Understanding the 505(b)(2) Approval Pathway

CMC for 505(b)(2) Applications

Measurement of Elemental Impurities in Pharmaceutical Products by ICP-AES and ETAAS

ImmunoSIGNAL™ Cytokine Storm

Development of an In Vitro Pre-clinical Cellular Assay to Predict

Resources Filter